Zobrazeno 1 - 10
of 24
pro vyhledávání: '"M M, Luchetti"'
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
Externí odkaz:
https://doaj.org/article/929283d0121d4ceaacd87fdf7d1dd39d
Autor:
M. S. Chimenti, M. Galluzzo, M. Talamonti, A. Campanati, C. Bonifati, P. Bruni, G. Caldarola, A. Carpentieri, A. Chiricozzi, C. De Simone, F. Diotallevi, M. Esposito, C. Fiorella, D. Graceffa, F. Loconsole, K. Hansel, C. Mugheddu, M. Papini, A. Richetta, A. Bergamini, M. M. Luchetti, L. Atzori, K. Peris, A. Offidani, L. Stingeni, L. Bianchi
Publikováno v:
Annals of the Rheumatic Diseases. 81:1587.1-1587
BackgroundPsoriasis (PSO) is a systemic immune-mediated disorder, characterized by inflammation skin and joint manifestations: it is known that up to 30% of PsO patients develop PsA.PsO and PsA share common etiopathogenetic pathways, as IL-23/IL-17 a
Autor:
M M, Luchetti, P, Sambo, P, Majlingová, S, Svegliati Baroni, G, Peri, P, Paroncini, M, Introna, A, Stoppacciaro, A, Mantovani, A, Gabrielli
Publikováno v:
Clinical and experimental rheumatology. 22(3 Suppl 33)
PTX3 is a secreted molecule which consists of a C-terminal domain similar to classical pentraxins (e.g. C-reactive protein) and of an unrelated N-terminal domain. Unlike the classical pentraxins, PTX3 is expressed in response to IL-1beta and TNF-alph
Publikováno v:
Clinical and experimental rheumatology. 10(5)
The C5b-9 complex (Terminal Complement Complex-TCC) is the final product of the terminal complement pathway. In this study, using the monoclonal antibody MCaE11 (specific for a C9 neoantigen) and an immunohistochemical technique, we examined the TCC
Autor:
A, Corvetta, A, Giovagnoni, S, Baldelli, P, Ercolani, G, Pomponio, M M, Luchetti, N, Rinaldi, E, De Nigris
Publikováno v:
Clinical and experimental rheumatology. 10(3)
The purpose of this study was to evaluate the diagnostic accuracy of magnetic resonance imaging (MRI) in rheumatoid arthritis (RA) by comparing MRI with conventional radiology (CR) findings and by correlating these findings with the clinical and sero
Publikováno v:
Clinical and experimental rheumatology. 9(2)
A new reversed-phase high-performance liquid chromatography (HPLC) technique was employed in order to monitor the plasma Tenoxicam (TNX) levels in 13 patients affected by rheumatoid arthritis who were participating in a short-term, controlled, random
Autor:
Caggiari L; Division of Experimental Oncology I, IRCCS, Centro di Riferimento Oncologico, Aviano (PN), Italy., Simula MP, Marzotto A, Caragnano A, Luchetti M, Gabrielli A, De Re V
Publikováno v:
Tissue antigens [Tissue Antigens] 2005 Sep; Vol. 66 (3), pp. 246-7.
Autor:
Nesci S; Laboratorio di Ricerca di Onco-Ematologia, Dipartimento di Onco-Ematologia, Azienda Ospedale 'San Salvatore', Pesaro, Italy. s.nesci@ospedalesansalvatore.it, Buffi O, Iliescu A, Luchetti M, Battarra MR, Amadei M, Visani G, Andreani M
Publikováno v:
Tissue antigens [Tissue Antigens] 2004 Mar; Vol. 63 (3), pp. 282-3.
Autor:
Sambo P; Università di Ancona, Italy., Baroni SS, Luchetti M, Paroncini P, Dusi S, Orlandini G, Gabrielli A
Publikováno v:
Arthritis and rheumatism [Arthritis Rheum] 2001 Nov; Vol. 44 (11), pp. 2653-64.
Autor:
Ashford RU; The WHO Collaborating Centre for Metabolic Bone Diseases, University of Sheffield Medical School, England., Luchetti M, McCloskey EV, Gray RL, Pande KC, Dey A, Kayan K, Ralston SH, Kanis JA
Publikováno v:
Calcified tissue international [Calcif Tissue Int] 2001 Jun; Vol. 68 (6), pp. 348-51. Date of Electronic Publication: 2001 May 21.